Metraipolis › archive › dc_b673375e2ecf
Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques — Europe PMC PMID:37399208
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/37399208
- DOI
- 10.1371/journal.ppat.1011059
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-07T12:58:09.708Z
- SHA-256 of the archived text
98b4eea4bf86fc44397bf35050abc8b0366c529a1c90a5773e60389b4f2b1856- Stable URL of this page
https://metraipolis.com/documento/dc_b673375e2ecf
How to cite
Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques — Europe PMC PMID:37399208 — Europe PMC (en), https://europepmc.org/article/MED/37399208 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_b673375e2ecf (Metraipolis archive dc_b673375e2ecf, sha256 98b4eea4bf86fc44397bf35050abc8b0366c529a1c90a5773e60389b4f2b1856)
BibTeX
@misc{dcb673375e2ecf,
title = {Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques — Europe PMC PMID:37399208},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/37399208},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_b673375e2ecf; sha256 98b4eea4bf86fc44397bf35050abc8b0366c529a1c90a5773e60389b4f2b1856},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/37399208. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Transmitted/founder (TF) simian-human immunodeficiency viruses (SHIVs) express HIV-1 envelopes modified at position 375 to efficiently infect rhesus macaques while preserving authentic HIV-1 Env biology. SHIV.C.CH505 is an extensively characterized virus encoding the TF HIV-1 Env CH505 mutated at position 375 shown to recapitulate key features of HIV-1 immunobiology, including CCR5-tropism, a tier 2 neutralization profile, reproducible early viral kinetics, and authentic immune responses. SHIV.C.CH505 is used frequently in nonhuman primate studies of HIV, but viral loads after months of infection are variable and typically lower than those in people living with HIV. We hypothesized that additional mutations besides Δ375 might further enhance virus fitness without compromising essential components of CH505 Env biology. From sequence analysis of SHIV.C.CH505-infected macaques across multiple experiments, we identified a signature of envelope mutations associated with higher viremia. We then used short-term in vivo mutational selection and competition to identify a minimally adapted SHIV.C.CH505 with just five amino acid changes that substantially improve virus replication fitness in macaques. Next, we validated the performance of the adapted SHIV in vitro and in vivo and identified the mechanistic contributions of selected mutations. In vitro, the adapted SHIV shows improved virus entry, enhanced replication on primary rhesus cells, and preserved neutralization profiles. In vivo, the minimally adapted virus rapidly outcompetes the parental SHIV with an estimated growth advantage of 0.14 days-1 and persists through suppressive antiretroviral therapy to rebound at treatment interruption. Here, we report the successful generation of a well-characterized, minimally adapted virus, termed SHIV.C.CH505.v2, with enhanced replication fitness and preserved native Env properties that can serve as a new reagent for NHP studies of HIV-1 transmission, pathogenesis, and cure. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS pathogens, 2023 (prima pubblicazione 2023-07-03). Identificativi: PMID 37399208 · PMCID PMC10348547 · DOI 10.1371/journal.ppat.1011059. Descrittori MeSH principali: HIV-1; HIV Infections; HIV Seropositivity; Simian Acquired Immunodeficiency Syndrome; Simian immunodeficiency virus. Pagina: https://europepmc.org/article/MED/37399208 — https://doi.org/10.1371/journal.ppat.1011059. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-07T12:28:09.719Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.